KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Teva Pharmaceutical Industries (TEVA) Other Non-Current Assets (2016 - 2025)

Teva Pharmaceutical Industries' Other Non-Current Assets history spans 17 years, with the latest figure at $1.8 billion for Q4 2025.

  • For the quarter ending Q4 2025, Other Non-Current Assets rose 298.7% year-over-year to $1.8 billion, compared with a TTM value of $1.8 billion through Dec 2025, up 298.7%, and an annual FY2025 reading of $1.8 billion, up 298.7% over the prior year.
  • Other Non-Current Assets for Q4 2025 was $1.8 billion at Teva Pharmaceutical Industries, up from $444.0 million in the prior quarter.
  • The five-year high for Other Non-Current Assets was $1.8 billion in Q4 2025, with the low at $13.0 million in Q1 2022.
  • Average Other Non-Current Assets over 5 years is $390.0 million, with a median of $447.0 million recorded in 2023.
  • Year-over-year, Other Non-Current Assets plummeted 97.52% in 2022 and then soared 3361.54% in 2023.
  • Tracing TEVA's Other Non-Current Assets over 5 years: stood at $515.0 million in 2021, then dropped by 14.37% to $441.0 million in 2022, then tumbled by 84.13% to $70.0 million in 2023, then skyrocketed by 560.0% to $462.0 million in 2024, then skyrocketed by 298.7% to $1.8 billion in 2025.
  • Per Business Quant, the three most recent readings for TEVA's Other Non-Current Assets are $1.8 billion (Q4 2025), $444.0 million (Q3 2025), and $470.0 million (Q2 2025).